Stockreport

Assessing Erasca (ERAS) Valuation After ERAS-0015 Licensing Win And Data Anticipation [Yahoo! Finance]

Erasca, Inc.  (ERAS) 
PDF Erasca stock moves on ERAS-0015 licensing and clinical data anticipation Erasca (ERAS) has been in focus after securing exclusive global rights to its pan RAS candida [Read more]